Literature DB >> 7693140

The notification of infectious diseases in England and Wales.

A McCormick.   

Abstract

For nearly a hundred years, it has been a statutory requirement for doctors to notify a Proper Officer of the local authority (now, usually, the Consultant in Communicable Disease Control) of cases of certain infectious diseases. This prompts local investigation and appropriate action to control the disease. These data are also used for the analysis of local and national trends. This article describes how the notification system has evolved, its legal basis, and some of its strengths and weaknesses, and suggests how improvements could be achieved. Trends in notification data are presented for several diseases and compared with data derived from other sources.

Entities:  

Mesh:

Year:  1993        PMID: 7693140

Source DB:  PubMed          Journal:  Commun Dis Rep CDR Rev        ISSN: 1350-9349


  5 in total

1.  Mumps and the media: changes in the reporting of mumps in response to newspaper coverage.

Authors:  Babatunde Olowokure; Lilian Clark; Alex J Elliot; Douglas Harding; Ann Fleming
Journal:  J Epidemiol Community Health       Date:  2007-05       Impact factor: 3.710

2.  Trends in imported childhood malaria in the UK: 1999-2003.

Authors:  S Ladhani; R J Aibara; M Blaze; V Smith; D V Shingadia
Journal:  Arch Dis Child       Date:  2006-06-28       Impact factor: 3.791

Review 3.  Treatment of traveller's diarrhoea. Economic aspects.

Authors:  M A Thomson; I W Booth
Journal:  Pharmacoeconomics       Date:  1996-05       Impact factor: 4.981

Review 4.  An evaluation of completeness of tuberculosis notification in the United Kingdom.

Authors:  Jayshree Pillaye; Aileen Clarke
Journal:  BMC Public Health       Date:  2003-10-06       Impact factor: 3.295

5.  Working conditions and tuberculosis mortality in England and Wales, 1890-1912: a retrospective analysis of routinely collected data.

Authors:  Charlotte Jackson; Joanna H Mostowy; Helen R Stagg; Ibrahim Abubakar; Nick Andrews; Tom A Yates
Journal:  BMC Infect Dis       Date:  2016-05-20       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.